Breaks Categories: News

FridayJun 10, 2022 11:40 am

NetworkNewsBreaks – Marathon Digital Holdings Inc. (NASDAQ: MARA) Announces May 2022 BTC Production, Mining Operation Updates

Marathon Digital Holdings (NASDAQ: MARA), one of the largest enterprise bitcoin self-mining companies in North America, today published unaudited bitcoin (“BTC”) production and miner installation updates for May 2022. “Although we continue to install miners at the Texas facilities, we have experienced delays in energization as Compute North’s energy provider awaits federal agency confirmation of its exempt status for tax purposes based upon its arrangements with Compute North. While these delays have been disappointing, our current understanding is that miners should start to come online this month. We continue to work closely and actively engage with Compute North to gain…

Continue Reading

FridayJun 10, 2022 11:26 am

NetworkNewsBreaks – Bluejay Diagnostics Inc. (NASDAQ: BJDX) Announces Continued Advancement of Symphony IL-6 Test

Bluejay Diagnostics (NASDAQ: BJDX), a medical diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, has announced that the FDA has agreed to consider Bluejay’s plan to pursue a De Novo submission for the Symphony IL-6 Test. “We are excited for the opportunity to pursue the De Novo regulatory pathway,” said Bluejay’s Chief Executive Officer Neil Dey. “This confirms our belief that the Bluejay Symphony IL-6 Test has the potential to provide an innovative solution to the market. Bluejay continues to advance the Symphony IL-6 Test towards the company’s anticipated marketing application with…

Continue Reading

FridayJun 10, 2022 10:53 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Awarded Board Approval for CYB003 Phase 1/2a Clinical Trial

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, received Institutional Review Board (“IRB”) approval to begin its planned phase 1/2a clinical trial. The trial, the first-in-human phase 1/2a trial evaluating CYBN’s proprietary deuterated psilocybin analog CYB003, is slated to begin in mid-2022.The study will evaluate CYB003 for the treatment of major depressive disorder (“MDD”).  Cybin applied for IRB approval just last month. According to the announcement, Cybin wholly owned subsidiary Cybin IRL Limited has partnered with Clinilabs Drug Development Corporation to conduct the randomized, double-blind, placebo-controlled study. The study involves participants receiving two administrations of…

Continue Reading

ThursdayJun 09, 2022 3:11 pm

NetworkNewsBreaks – Cboe Global Markets Inc. (CBOE: CBOE) Leveraging Acquisition to Provide Enhanced Canadian Equities Offering

Cboe Global Markets (CBOE: CBOE), a leading provider of global market infrastructure and tradable products, recently announced its acquisition of NEO*, a fintech organization comprised of a fully registered Canadian securities exchange (“NEO Exchange”) with a diverse product and services set ranging from corporate listings to cash equities trading and a non-listed securities distribution platform (“NEO Connect”). Through the acquisition, Cboe expects to provide an enhanced Canadian equities offering, bringing global infrastructure and market expertise to further grow Canada as a hub for global equities trading. “With NEO, we are creating another connection across borders through our network of trusted…

Continue Reading

ThursdayJun 09, 2022 3:05 pm

NetworkNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR) Inks Licensing, Distribution Deal with Global iGaming Supplier

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR), a propriety SaaS technology company delivering mobile-first live-dealer technology to online gaming operators globally, has signed a software license and distribution agreement with Markor Technology, a global iGaming supplier. Markor Technology has built a reputation for offering products driven by data science and machine-learning automation. The company’s multivertical portfolio includes state-of-the-art iGaming platform (“PAM”), white-label solutions, game aggregation and managed services. According to the three-year agreement, Markor Technology will add Playgon's exclusive, mobile-first Vegas Lounge live dealer and e-table offerings to its content library, where it will be available to a global…

Continue Reading

ThursdayJun 09, 2022 2:46 pm

NetworkNewsBreaks – Quantum World Congress to Showcase Innovations to ‘Transform How the World Lives, Works and Learns’

Connected DMV and MCI USA today announced the inaugural Quantum World Congress, a first-of-its-kind global quantum conference, exposition and networking series. The event is slated to take place Nov. 29–Dec. 1, 2022, at the Ronald Reagan Building and International Trade Center in Washington, D.C. The annual conference will establish Greater Washington as the go-to destination and meeting place for quantum technology visionaries, policymakers, researchers, business and investment leaders and students. Designed to attract a cross-sector and multi-disciplinary audience, the event will showcase major trends in quantum solutions, research, education, workforce, thought leadership, policy, business and investment. “Quantum will soon deliver…

Continue Reading

ThursdayJun 09, 2022 2:43 pm

NetworkNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Engages IBN for Corporate Communications Expertise

Aditxt (NASDAQ: ADTX), a biotech innovation company, today announced that it has selected the corporate communications expertise of IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company for private and public entities. As part of the relationship, IBN will leverage its investor based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs, and other outreach tools to generate greater awareness for Aditxt. “The potential market opportunities presented by immune monitoring and reprogramming are extensive. Through its work in the COVID-19 testing market with AditxtScore(TM), Aditxt demonstrated this potential. The company is now…

Continue Reading

ThursdayJun 09, 2022 2:22 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX), Rogue Station Companies Inc./Everdime Inc. (RGST) Enter Partnership to Enhance Investor Communications

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has entered a partnership with Rogue Station Companies/Everdime (OTC: RGST). Through SRAX, RGST, a crypto and blockchain development company building the technology bridge that connects what is real and the new augmented reality within the metaverse, will have the ability to further reach its community through sophisticated solutions. “The RGST/Everdime team warmly welcomes our recent partnership with SRAX,” said RGST CEO Sandor Miklos. “As our company continues BETA testing its apps and prepares to launch its token and…

Continue Reading

ThursdayJun 09, 2022 2:13 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Portfolio of Rare Cannabinoids with Launch of d9-THCV

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced its launch of B2B sales of the rare cannabinoid delta 9-dominant tetrahydrocannabivarin (“d9-THCV”) into the health and wellness sector via its wholly owned subsidiary, BayMedica LLC. “We are very excited to launch our highly anticipated d9-THCV and further enhance BayMedica’s growing product portfolio,” said Shane Johnson, MD, SVP and general manager of BayMedica. “THCV is one of the few rare cannabinoids that has been researched in early clinical trials for various therapeutic effects, fueling significant interest by end-product manufacturers and consumers alike.…

Continue Reading

ThursdayJun 09, 2022 1:21 pm

NetworkNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Announces Approval of NCIB by TSX Venture Exchange

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, today announced that the TSX Venture Exchange (“TSXV”) has approved the company’s Normal Course Issuer Bid (“NCIB”). The NCIB will allow EverGen to purchase issued and outstanding common shares of EverGen through the facilities of the TSXV during a 12 month period, commencing on June 8, 2022, and ending on June 7, 2023, or such earlier date as EverGen may complete its purchases pursuant to the NCIB or as it may otherwise determine. According to the update, the company implemented the NCIB because it believes that, from time…

Continue Reading